Structure | Chemical Name | CAS | MF |
|
N-(3-Sodiooxycrotonoyl)-2,4-dimethoxyaniline
|
|
C12H14NNaO4
|
|
5-[N-Sodio-N-(p-aminophenylsulfonyl)amino]-3,4-dimethyl-2-isoxazoline
|
|
C11H14N3NaO3S
|
|
N-[[(Sodiooxy)carbonyl]methyl]-N-(6-octenyl)glycine
|
|
C12H20NNaO4
|
|
N-(7-Sodiooxy-1-naphtyl)acetamide
|
|
C12H10NNaO2
|
|
N-[[(Sodiooxy)carbonyl]methyl]-N-octylglycine
|
|
C12H22NNaO4
|
|
5-[N'-[3-Sodiooxycarbonyl-4-[[2-oxo-1-(phenylaminocarbonyl)propyl]azo]phenyl]ureido]-2-[[4,5-dihydro-3-methyl-5-oxo-1-(3-sodiosulfophenyl)-1H-pyrazol-4-yl]azo]benzoic acid sodium salt
|
|
C35H25N9Na4O11S
|
|
N-(3-Sodiooxycrotonoyl)-2,4-dimethylaniline
|
|
C12H14NNaO2
|
|
N-[[(Sodiooxy)carbonyl]methyl]-N-(7-octenyl)glycine
|
|
C12H20NNaO4
|
|
N-Sodiodiethylamine
|
34992-80-8
|
|
|
N-Sodio-2-methylbenzenesulfonamide
|
|
C7H8NNaO2S
|
|
N-(3-Sodiooxycrotonoyl)-2-methoxy-5-chloroaniline
|
|
C11H11ClNNaO3
|
|
N-[2-(Sodiooxysulfonyl)ethyl]-3β-hydroxy-11-oxoolean-12-en-30-amide
|
|
|
|
N-[2-[[(Sodiooxy)sulfonyl]thio]propionyl]-L-alanine
|
|
C6H10NNaO6S2
|
|
N-(3-Sodiooxycrotonoyl)aniline
|
|
C10H10NNaO2
|
|
N-(2-Sodiooxyphenyl)-N-sodiosulfo-4-methylbenzenesulfonamide
|
|
C13H11NNa2O6S2
|
|
N-[[(Sodiooxy)carbonyl]methyl]-N-(3-octenyl)glycine
|
|
C12H20NNaO4
|
|
N-[2-[(Sodiosulfo)oxy]ethyl]octadecanamide
|
14351-59-8
|
C20H41NO5S.Na
|
|
N-[[(Sodiooxy)carbonyl]methyl]-N-(2-octenyl)glycine
|
|
C12H20NNaO4
|
|
N-(3-Sodiooxycrotonoyl)-2,5-dimethoxyaniline
|
|
C12H14NNaO4
|
|
N-(2-Sodiooxycarbonyl-9H-fluoren-9-ylidene)-4-[bis(2-hydroxyethyl)amino]phenylamineN-oxide
|
|
|
|
NTE-122 DIHYDROCHLORIDE
|
166967-84-6
|
C38Cl2H60N6O2
|
|
N-(SODIUMSULPHOETHYL)OLEAMIDE
|
101975-70-6
|
|
|
N-(3-Sodiooxycrotonoyl)-2-chloroaniline
|
|
C10H9ClNNaO2
|
|
N-(3-Sodiooxycrotonoyl)-4-ethoxyaniline
|
|
C12H14NNaO3
|
|
N-[2-[(Sodiosulfo)oxy]propyl]dodecanamide
|
26535-46-6
|
C15H31NO5S.Na
|
|
N-[[(Sodiooxy)carbonyl]methyl]-N-(1-octenyl)glycine
|
|
C12H20NNaO4
|
|
N-[[(Sodiooxy)carbonyl]methyl]-N-(5-octenyl)glycine
|
|
C12H20NNaO4
|
|
N-(3-Sodiooxycrotonoyl)-2,4-dimethoxy-5-chloroaniline
|
|
C12H13ClNNaO4
|
|
N-Sodio-N-(6-methoxy-4-pyrimidinyl)-4-aminobenzenesulfonamide
|
|
C11H11N4NaO3S
|
|
N-Sodio-N-[2-(sodiooxysulfonyloxy)phenyl]-4-methylbenzenesulfonamide
|
|
C13H11NNa2O6S2
|
|
N-(3-Sodiooxycrotonoyl)-2-methoxyaniline
|
|
C11H12NNaO3
|
|
N-(3-Sodiooxycrotonoyl)-4-methylaniline
|
|
C11H12NNaO2
|
|
N-(3-Sodiooxycrotonoyl)-4-methoxyaniline
|
|
C11H12NNaO3
|
|
N-(Sodiothiocarbonothioyl)-L-glutamic acid disodium salt
|
75808-54-7
|
C6H9NO4S2
|
|
N-Sodiumsulfomethylglycine
|
75032-88-1
|
|
|
N-(3-Sodiooxycrotonoyl)-2,5-dimethoxy-4-chloroaniline
|
|
C12H13ClNNaO4
|
|
N-(Sodiocarboxymethyl)-N,N-dimethyl-1-dodecanaminium
|
|
C16H33NNaO2+
|
|
N-(3-Sodiooxycrotonoyl)-2-ethoxyaniline
|
|
C12H14NNaO3
|
|
N-[2-(Sodiooxy)phenyl]acetamide
|
|
C8H8NNaO2
|
|
N-[(Sodiooxycarbonyl)methyl]-N,N-dimethyl-3-[(1-oxododecyl)amino]-1-propanaminium
|
|
C19H38N2NaO3+
|
|
N-[(Sodiothio)carbonothioyl]-L-alanine sodium salt
|
75808-41-2
|
C4H8NNaO2S2
|
|
N-[[(2S)-1-Octylpyrrolidin-2α-yl]methyl]-2-methoxy-5-sulfamoylbenzamide
|
|
|
|
NTCYC1 protein
|
|
|
|
N-[[(2S)-1-Nonylpyrrolidin-2α-yl]methyl]-2-methoxy-5-sulfamoylbenzamide
|
|
|
|
NSP 805
|
125068-54-4
|
C17H19N3O2
|
|
NSP 804
|
125068-43-1
|
C16H17N3O2
|
|
NTF2
|
|
|
|
NS3-NS3a protein, African horsesickness virus
|
|
|
|
N2-[[(3S)-2-[N2-[(2S)-2-Amino-3-phenylpropyl]-L-Lys-]-2-azabicyclo[2.2.2]octan-3-yl]carbonyl]-L-Arg-OH
|
|
|
|
NtDSK1
|
|
|
|
N2-[[(3S)-2-[N2-[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutanoyl]-L-Lys-]-2-azabicyclo[2.2.2]octan-3-yl]carbonyl]-L-Arg-OH
|
|
|
|
2-(N-TFA)aminoheptane
|
|
|
|
N-TFA-3-AMINO-1,2-EPOXYPROPANE
|
|
C5H6F3NO2
|
|
1-(N-TFA)aminoindan
|
|
|
|
N-TFA C6 AMINOMODIFIER
|
|
|
|
N-TFA-DL-METHIONINE METHYL ESTER
|
1808-40-8
|
C8H12F3NO3S
|
|
N-TFA-DL-THREONINE METHYL ESTER
|
88494-53-5
|
C7H10F3NO4
|
|
NSP1 adaptor protein
|
|
|
|
NSP3 adaptor protein
|
|
|
|
NSP2 adaptor protein
|
|
|
|
NTF2-AGAROSE
|
|
|
|
N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine
|
103190-36-9
|
C65H100N2O4
|
|
N-TFA-L-ALANINE METHYL ESTER
|
25518-39-2
|
C6H8F3NO3
|
|
N-TFA-L-TRYPTOPHAN METHYL ESTER
|
1604-49-5
|
C14H13F3N2O3
|
|
N-TFA-L-METHIONINE METHYL ESTER
|
1830-73-5
|
C8H12F3NO3S
|
|
N-TFA-L-PROLINE METHYL ESTER
|
715-58-2
|
C8H10F3NO3
|
|
1-(N-TFA)-2-Methylpiperidine
|
|
|
|
(-)-N-[(S)-p-Amino-α-methylbenzyl]phthalimide
|
|
|
|
NSP-A & NSP-B (neuro-endocrine specific protein), Clone: RNL-3, Mab anti-Human, Rat, frozen, IH/WB
|
|
|
|
NSP-A & NSP-B (neuro-endocrine specific protein), Clone: RNL-2, Mab anti-Human, Rat, frozen, IH/WB
|
|
|
|
NspA protein
|
|
|
|
(-)-N-[(S)-p-Bromo-α-methylbenzyl]phthalimide
|
|
|
|
(-)-N-[(S)-p-Chloro-α-methylbenzyl]phthalimide
|
|
|
|
NSP-C (neuro-endocrine specific protein), Clone: RNL-4, Mab anti-Human, Rat,frzn/prfn, IH/WB
|
|
|
|
2',6'-DiMethylcarbonylphenyl-10-sulfopropylacridiniuM-9-carboxylate 4'-NHS Ester
|
194357-64-7
|
C30H26N2O9S
|
|
(-)-N-[2-[(S)-1-O,2-O-Dipalmitoyl-D-glycero-3-phospho]ethyl]phthalimide
|
|
|
|
(+)-N-[2-[(S)-1-O,2-O-Dioctadecyl-D-glycero-3-phospho]ethyl]phthalimide
|
|
|
|
(+)-N-[2-[(S)-1-O,2-O-Dihexadecyl-D-glycero-3-phospho]ethyl]phthalimide
|
|
|
|
(-)-N-[2-[[(S)-1-O,2-O-Dimyristoyl-D-glycero-3-phospho]oxy]ethyl]acetamide
|
|
|
|
(-)-N-[2-[(S)-1-O,2-O-Dimyristoyl-D-glycero-3-phospho]ethyl]phthalimide
|
|
|
|
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester
|
1334513-02-8
|
C18H17F5NO5P
|
|
N-[(S)-1-(Pentachlorophenyl)-2-methyl-2-propenyl]-4-methylbenzenesulfonamide
|
|
C17H14Cl5NO2S
|
|
N-Teracosanoyl-D-Spingosine
|
|
|
|
N-(1,1':4',1''-Terbenzen-4-yl)acetamide
|
64058-92-0
|
C20H17NO
|
|
N-[(1S)-1-Phenylethyl](2-thienyl)methaneimine
|
|
C13H13NS
|
|
(+)-N-[(S)-1-(4-Phenyl-2-thiazolyl)ethyl]benzamide
|
|
C18H16N2OS
|
|
N-[(S)-1-Phenyl-2-cyanoethyl]-p-toluenesulfonamide
|
|
C16H16N2O2S
|
|
N-[(1S)-1-Phenylethyl]-3-hydroxy-2,2-dimethylpropanamide
|
|
C13H19NO2
|
|
N-[(1S)-1-Phenylethyl]-3-(acetyloxy)-2,2-dimethylpropanamide
|
|
C15H21NO3
|
|
(+)-N-[(S)-α-Phenylphenacyl]formamide
|
|
|
|
N-[(S)-1-Phenylbutan-2-yl]adenosine
|
|
C20H25N5O4
|
|
N-[(1S)-1-Phenylethyl]-1-phenylethylideneamine
|
|
C16H17N
|
|
N1-[3-[[(S)-1-Phenylethyl]amino]propyl]-7,8-dihydrobleomycinamide
|
79736-64-4
|
C61H90N18O21S2
|
|
N-[(S)-1-Phenylethyl]-4-nitrobenzenesulfonamide
|
|
C14H14N2O4S
|
|
1-N-[1-(S)-PHENYL-ETHYL]-PYROLIND-3-ONE
|
|
|
|
NSP1, Goat anti-, WB
|
|
|
|
N-(1(S)-PHENYLETHYL)-6-FORML-2,3-DIHYDRO-1,4-BENZODIOXINE-2-(R)-CARBOXAMIDE
|
227091-47-6
|
C18H17NO4
|
|
N-(S)-1-(1-PHENYLETHYL)-3-PYRROLIDINONE
|
|
C12H15NO
|
|
N-[(1S)-1-PHENYLETHYL]-8-THIEN-3-YL-1,6-NAPHTHYRIDINE-2-CARBOXAMIDE
|
|
C21H17N3OS
|
|
N-[(S)-(-)-1-PHENYLETHYL]IMIDAZOLE-1-CARBOXAMIDE
|
151252-80-1
|
C12H13N3O
|